223 related articles for article (PubMed ID: 10362144)
1. Influence of MUC18/MCAM/CD146 expression on human melanoma growth and metastasis in SCID mice.
Schlagbauer-Wadl H; Jansen B; Müller M; Polterauer P; Wolff K; Eichler HG; Pehamberger H; Konak E; Johnson JP
Int J Cancer; 1999 Jun; 81(6):951-5. PubMed ID: 10362144
[TBL] [Abstract][Full Text] [Related]
2. Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
Jean D; Gershenwald JE; Huang S; Luca M; Hudson MJ; Tainsky MA; Bar-Eli M
J Biol Chem; 1998 Jun; 273(26):16501-8. PubMed ID: 9632718
[TBL] [Abstract][Full Text] [Related]
3. Expression of MCAM/MUC18 by human melanoma cells leads to increased tumor growth and metastasis.
Xie S; Luca M; Huang S; Gutman M; Reich R; Johnson JP; Bar-Eli M
Cancer Res; 1997 Jun; 57(11):2295-303. PubMed ID: 9187135
[TBL] [Abstract][Full Text] [Related]
4. Melanoma progression-associated glycoprotein MUC18/MCAM mediates homotypic cell adhesion through interaction with a heterophilic ligand.
Johnson JP; Bar-Eli M; Jansen B; Markhof E
Int J Cancer; 1997 Nov; 73(5):769-74. PubMed ID: 9398060
[TBL] [Abstract][Full Text] [Related]
5. MUC18/MCAM (CD146), an activation antigen of human T lymphocytes.
Pickl WF; Majdic O; Fischer GF; Petzelbauer P; Faé I; Waclavicek M; Stöckl J; Scheinecker C; Vidicki T; Aschauer H; Johnson JP; Knapp W
J Immunol; 1997 Mar; 158(5):2107-15. PubMed ID: 9036955
[TBL] [Abstract][Full Text] [Related]
6. Fully human antibodies to MCAM/MUC18 inhibit tumor growth and metastasis of human melanoma.
Mills L; Tellez C; Huang S; Baker C; McCarty M; Green L; Gudas JM; Feng X; Bar-Eli M
Cancer Res; 2002 Sep; 62(17):5106-14. PubMed ID: 12208768
[TBL] [Abstract][Full Text] [Related]
7. Direct correlation between MUC18 expression and metastatic potential of human melanoma cells.
Luca M; Hunt B; Bucana CD; Johnson JP; Fidler IJ; Bar-Eli M
Melanoma Res; 1993 Feb; 3(1):35-41. PubMed ID: 8471835
[TBL] [Abstract][Full Text] [Related]
8. Ectopic expression of MCAM/MUC18 increases in vitro motility and invasiveness, but decreases in vivo tumorigenesis and metastasis of a mouse melanoma K1735-9 subline in a syngeneic mouse model.
Wu GJ
Clin Exp Metastasis; 2016 Dec; 33(8):817-828. PubMed ID: 27510563
[TBL] [Abstract][Full Text] [Related]
9. Enforced expression of MCAM/MUC18 increases in vitro motility and invasiveness and in vivo metastasis of two mouse melanoma K1735 sublines in a syngeneic mouse model.
Wu GJ; Fu P; Wang SW; Wu MW
Mol Cancer Res; 2008 Nov; 6(11):1666-77. PubMed ID: 19010815
[TBL] [Abstract][Full Text] [Related]
10. Cell adhesion molecules in the development and progression of malignant melanoma.
Johnson JP
Cancer Metastasis Rev; 1999; 18(3):345-57. PubMed ID: 10721489
[TBL] [Abstract][Full Text] [Related]
11. Identification of the elements regulating the expression of the cell adhesion molecule MCAM/MUC18. Loss of AP-2 is not required for MCAM expression in melanoma cell lines.
Mintz-Weber CS; Johnson JP
J Biol Chem; 2000 Nov; 275(44):34672-80. PubMed ID: 10938273
[TBL] [Abstract][Full Text] [Related]
12. Role of AP-2 in tumor growth and metastasis of human melanoma.
Bar-Eli M
Cancer Metastasis Rev; 1999; 18(3):377-85. PubMed ID: 10721491
[TBL] [Abstract][Full Text] [Related]
13. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells.
Xie S; Price JE; Luca M; Jean D; Ronai Z; Bar-Eli M
Oncogene; 1997 Oct; 15(17):2069-75. PubMed ID: 9366524
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.
Aldrian S; Kindas-Mügge I; Trautinger F; Fröhlich I; Gsur A; Herbacek I; Berger W; Micksche M
Cell Stress Chaperones; 2003; 8(3):249-57. PubMed ID: 14984058
[TBL] [Abstract][Full Text] [Related]
15. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
16. Gene regulation in melanoma progression by the AP-2 transcription factor.
Bar-Eli M
Pigment Cell Res; 2001 Apr; 14(2):78-85. PubMed ID: 11310795
[TBL] [Abstract][Full Text] [Related]
17. Mel-CAM-specific genetic suppressor elements inhibit melanoma growth and invasion through loss of gap junctional communication.
Satyamoorthy K; Muyrers J; Meier F; Patel D; Herlyn M
Oncogene; 2001 Aug; 20(34):4676-84. PubMed ID: 11498790
[TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of mouse MUC18 cDNA gene, and correlation of MUC18 expression in mouse melanoma cell lines with metastatic ability.
Yang H; Wang S; Liu Z; Wu MH; McAlpine B; Ansel J; Armstrong C; Wu G
Gene; 2001 Mar; 265(1-2):133-45. PubMed ID: 11255016
[TBL] [Abstract][Full Text] [Related]
19. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo.
McGary EC; Heimberger A; Mills L; Weber K; Thomas GW; Shtivelband M; Lev DC; Bar-Eli M
Clin Cancer Res; 2003 Dec; 9(17):6560-6. PubMed ID: 14695161
[TBL] [Abstract][Full Text] [Related]
20. The cell-cell adhesion receptor Mel-CAM acts as a tumor suppressor in breast carcinoma.
Shih LM; Hsu MY; Palazzo JP; Herlyn M
Am J Pathol; 1997 Sep; 151(3):745-51. PubMed ID: 9284823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]